Keratoconus is a bilateral and progressive corneal disease characterized by a significant increase in irregular astigmatism and corneal thinning.
by compromising the ocular surface, a litany of serious complications could ensue. Nevertheless, still today penetrating keratoplasty (PK) and its cousin deep anterior lamellar keratoplasty (DALK) remain the standard of care for eyes with advanced keratoconus (KC) once visual acuity becomes unacceptable and/or contact lens intolerance develops. 1, 2 And while the outcomes of these operations are often described as "good," this may only be true in a relative sense, i.e. in comparison to the commonly disappointing results following transplantation for other indications, such as perforated ulcer or herpetic keratitis. 3, 4 In fact, many patients with advanced KC seem to be poor candidates for both PK and DALK. Nearly all are young, in some cases extremely so, making the surgeries themselves more technically challenging and the postoperative care more difficult, especially if there is some coexisting cognitive or behavioral limitation (which is not altogether uncommon). [5] [6] [7] [8] Young eyes also tend to be phakic: in the first few years after transplantation, many develop cataracts. As a result, lens extraction may be necessary, potentially risking the graft's health in the process. 9, 10 Children already suffer poorer graft survival than adults, 11 but even if the statistics were identical, still it is very likely that young patients will "outlive" their first transplant and therefore require re-operation(s). And because the outcomes of second and third transplants tend to be far inferior to the first, many patients who seem-initially-to "do well"
with both surgeries may, ultimately, be destined for problems. 12 This is especially true given that advanced KC is found in patients with severe ocular surface disorders, many of which are exacerbated by PK/DALK and their large incisions, sutures, and the neurotrophic corneas they produce. 13, 14 Beneath the ocular surface, the wound healing problems continue, since the stroma at the junction between the graft and the recipient probably never securely "heals," predisposing these eyes to inadvertent traumatic rupture and ongoing ectasia at the tissue interface (and thereby "recurrence" of their disease). are not approved in patients younger than 18 years old, and UV-CXL is not licensed yet.
Other exclusions also apply: corneas with prior herpetic disease are disqualified from UV-CXL, and a history of recurrent erosions rules out ICRS placement. Overall, it may be fair to say that, for various reasons, many patients with "active" or "ongoing" KC are ineligible for these disease-halting therapies, and are therefore allowed to continue to progress. 16, 17 Eventually, contact lens intolerance might develop. Many patients then receive either PK or DALK and subsequently suffer a lifetime of consequences.
What has been badly needed is an operation to arrest keratoconic progression in eyes poorly suited for UV-CXL or ICRS, before PK or DALK become necessary. For this reason, in 2014, we published our first results with a new operation known as Bowman layer transplantation (see Figure 1 ). 18 One of the most sensitive and specific manifestations of KC is the fragmentation of the Bowman layer, an insult that critically destabilizes the surrounding cornea, predisposing it to ongoing ectasia. As a result, we reasoned that an isolated Bowman layer transplant might flatten the cornea into a more normal architecture and bolster it against further deformation. So far, our experience with Bowman layer transplantation has led us to believe that the operation may be a promising way to arrest keratoconic progression, even in those eyes ineligible for other procedures. Further study will be necessary, but it is possible that with continued effort, we may continue in the tradition of endothelial keratoplasty by abandoning the idea of full thickness cornea transplantation and, instead, choose a more limited and specific corrective intervention. ■
